Status:
UNKNOWN
Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis
Lead Sponsor:
University Hospital, Angers
Conditions:
Sleep Apnea Syndrome
Nonalcoholic Steatohepatitis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study aims to evaluate the impact of nasal continuous positive airway pressure (nCPAP) treatment on liver enzymes in patients with sleep apnea syndrome and nonalcoholic steatohepatitis. Using a c...
Eligibility Criteria
Inclusion
- 18 to 70 years old
- Nonalcoholic steatohepatitis proven by liver biopsy
- Sleep apnea syndrome proven by polysomnography with an apnea-hypopnea index \> 10 events/hour
- Informed consent
Exclusion
- Psychiatric disorder
- Other cause of liver disease
- Professional driver
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00152711
Start Date
September 1 2004
Last Update
February 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Angers
Angers, France